In addition, inhibitors of apoptosis, particularly inhibitors of BCL-2 family members or caspases, have recently been introduced to target several chronic inflammatory diseases including NASH. This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatohepatitis.